Irinokabi 20 mg/ ml Norge - norsk - Statens legemiddelverk

irinokabi 20 mg/ ml

fresenius kabi oncology plc - irinotekanhydrokloridtrihydrat - konsentrat til infusjonsvæske, oppløsning - 20 mg/ ml

Pelmeg Den europeiske union - norsk - EMA (European Medicines Agency)

pelmeg

mundipharma corporation (ireland) limited - pegfilgrastim - nøytropeni - immunostimulants, - for å redusere varigheten av neutropenia og forekomsten av febrile neutropenia på grunn av kjemoterapi.

Libtayo Den europeiske union - norsk - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - karsinom, squamous cell - antineoplastiske midler - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Opdualag Den europeiske union - norsk - EMA (European Medicines Agency)

opdualag

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanom - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Crixivan Den europeiske union - norsk - EMA (European Medicines Agency)

crixivan

merck sharp & dohme b.v. - indinavir sulfat ethanolate - hiv-infeksjoner - antivirale midler til systemisk bruk - crixivan er angitt i kombinasjon med antiretrovirale nukleosidanaloger for behandling av hiv-1-infiserte voksne.

Suxamethonium chloride Aguettant 10 mg/ ml Norge - norsk - Statens legemiddelverk

suxamethonium chloride aguettant 10 mg/ ml

laboratoire aguettant - suksametoniumkloriddihydrat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 10 mg/ ml

Acitretin Orifarm 25 mg Norge - norsk - Statens legemiddelverk

acitretin orifarm 25 mg

orifarm generics a/s - acitretin - kapsel, hard - 25 mg

Acitretin Orifarm 10 mg Norge - norsk - Statens legemiddelverk

acitretin orifarm 10 mg

orifarm generics a/s - acitretin - kapsel, hard - 10 mg

Nephromag 0.2 mg/2.5 ml Norge - norsk - Statens legemiddelverk

nephromag 0.2 mg/2.5 ml

rotop pharmaka gmbh - mertiatid - preparasjonssett til radioaktive legemidler - 0.2 mg/2.5 ml

Latuda 18.5 mg Norge - norsk - Statens legemiddelverk

latuda 18.5 mg

2care4 aps - lurasidonhydroklorid - tablett, filmdrasjert - 18.5 mg